Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 70 of 70 entries
View as:

Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ

Phase: N/A Priority: Normal
NCT ID: NCT02962765 Org: User:
Start: 01/31/15 End: 08/20/20 Due: 08/20/21

Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency Diseases

Phase: N/A Priority: Normal
NCT ID: NCT00811174 Org: User:
Start: 01/31/09 End: 09/30/10 Due: 09/30/11

Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery

Phase: N/A Priority: Normal
NCT ID: NCT04918173 Org: User:
Start: 07/01/22 End: 12/01/25 Due: 12/01/26

Octaplas Adult TTP Trial

Phase: N/A Priority: Normal
NCT ID: NCT01938404 Org: User:
Start: 06/06/17 End: 08/02/17 Due: 08/02/18

Octaplas Pediatric Plasma Replacement Trial

Phase: N/A Priority: Normal
NCT ID: NCT02050841 Org: User:
Start: 12/31/14 End: 12/04/17 Due: 12/04/18

Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT03793426 Org: User:
Start: 01/28/21 End: 05/14/25 Due: 05/14/26

Use of Prothrombin Complex Concentrate in Patients Admitted in Emergency Care Units for Severe Bleeding While Receiving Oral Anticoagulants

Phase: N/A Priority: Normal
NCT ID: NCT03320603 Org: User:
Start: 10/13/17 End: 12/20/20 Due: 12/20/21

Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass

Phase: N/A Priority: Normal
NCT ID: NCT06096116 Org: User:
Start: 08/21/24 End: 12/31/26 Due: 12/31/27

Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT04867837 Org: User:
Start: 09/01/21 End: 12/31/26 Due: 12/31/27

Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP)

Phase: N/A Priority: Normal
NCT ID: NCT00411801 Org: User:
Start: 05/31/07 End: 02/29/08 Due: 02/28/09

Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression

Phase: N/A Priority: Normal
NCT ID: NCT04400058 Org: User:
Start: 06/01/20 End: 02/01/22 Due: 02/01/23

Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease VWD) Patients <6 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT04953884 Org: User:
Start: 07/28/21 End: 12/18/24 Due: 12/18/25

Effectiveness and Tolerability of Eqwilate in Real-life Conditions

Phase: N/A Priority: Normal
NCT ID: NCT04106908 Org: User:
Start: 11/27/19 End: 11/30/26 Due: 11/30/27

Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks

Phase: N/A Priority: Normal
NCT ID: NCT06361537 Org: User:
Start: 04/30/24 End: 06/30/27 Due: 06/30/28

Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00426270 Org: User:
Start: 06/30/06 End: 09/30/08 Due: 09/30/09

Octaplas Pediatric Plasma Exchange Trial

Phase: N/A Priority: Normal
NCT ID: NCT01938378 Org: User:
Start: 04/30/15 End: 01/27/19 Due: 01/27/20

Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT02638207 Org: User:
Start: 09/27/17 End: 09/05/19 Due: 09/05/20

Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT00989196 Org: User:
Start: 05/31/10 End: 09/30/12 Due: 09/30/13

Non-Interventional Study on the Tolerability and Efficacy of IVIG

Phase: N/A Priority: Normal
NCT ID: NCT02303093 Org: User:
Start: 08/01/11 End: 06/05/20 Due: 06/05/21

Study of Octaplex (Human Prothrombin Complex Concentrate) and Fresh Frozen Plasma in Patients Under Vitamin K Therapy Antagonist Needing Urgent Surgery or Invasive Procedures

Phase: N/A Priority: Normal
NCT ID: NCT00618098 Org: User:
Start: 05/31/08 End: 08/31/12 Due: 08/31/13